Phase II study of oral S-1 plus oral leucovorin in patients with previously treated non-small-cell lung cancer
Phase 2
- Conditions
- Pre-treated non-small cell lung cancer
- Registration Number
- JPRN-UMIN000004568
- Lead Sponsor
- Protocol team for S-1 with leucovorin therapy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
Not provided
Exclusion Criteria
patients with symptomatic brain metastasis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method response rate
- Secondary Outcome Measures
Name Time Method Safety, overall survival, progression free survival, and 1-year survival